Previous Close | 25.85 |
Open | 25.83 |
Bid | 25.77 x 1000 |
Ask | 25.79 x 900 |
Day's Range | 25.74 - 26.04 |
52 Week Range | 23.89 - 34.60 |
Volume | |
Avg. Volume | 1,355,778 |
Market Cap | 3.517B |
Beta (5Y Monthly) | 0.48 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.83 |
Earnings Date | Aug 02, 2024 |
Forward Dividend & Yield | 1.10 (4.27%) |
Ex-Dividend Date | Aug 30, 2024 |
1y Target Est | 36.25 |
Today, Opill®—the first and only daily birth control pill available without a prescription in the U.S.—announces the launch of its partnership with WNBA Star and two-time Olympic Gold Medalist Napheesa Collier. The collaboration builds on Opill's multi-year partnership with the Women's National Basketball Association (WNBA).
Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced a new brand partnership: Good Start®1 and Dr. Brown's®2 infant formula solutions. Good Start®, a trusted infant formula brand for over 50 years, and Dr. Brown's®, makers of the No. 1 pediatrician-recommended baby bottle in the U.S.3, share a long-time mission of creating confident feeding experiences for families.